Pub. Date : 2016
PMID : 27904617
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C. BACKGROUND: A dinucleotide variant rs368234815 in interferon lambda 4 (IFNL4) gene was recently found to be associated with the hepatitis C virus (HCV) treatment response. | Ribavirin | interferon lambda 4 (gene/pseudogene) | Homo sapiens |
| 2 | The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C. BACKGROUND: A dinucleotide variant rs368234815 in interferon lambda 4 (IFNL4) gene was recently found to be associated with the hepatitis C virus (HCV) treatment response. | Ribavirin | interferon lambda 4 (gene/pseudogene) | Homo sapiens |
| 3 | The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C. BACKGROUND: A dinucleotide variant rs368234815 in interferon lambda 4 (IFNL4) gene was recently found to be associated with the hepatitis C virus (HCV) treatment response. | Ribavirin | interferon lambda 4 (gene/pseudogene) | Homo sapiens |
| 4 | This study aimed to assess the impact of IFNL4 rs368234815 polymorphism on treatment response to pegylated-IFN alpha (Peg-IFN-alpha) and ribavirin (RBV) in hemophilic patients with chronic hepatitis C (CHC). | Ribavirin | interferon lambda 4 (gene/pseudogene) | Homo sapiens |
| 5 | This study aimed to assess the impact of IFNL4 rs368234815 polymorphism on treatment response to pegylated-IFN alpha (Peg-IFN-alpha) and ribavirin (RBV) in hemophilic patients with chronic hepatitis C (CHC). | Ribavirin | interferon lambda 4 (gene/pseudogene) | Homo sapiens |